176 related articles for article (PubMed ID: 37179793)
1. Selective internal radiotherapy in Germany: a review of indications and hospital mortality from 2012 to 2019.
Mertens A; Essing T; Minko P; Möllenhoff K; Mattes-György K; Giesel FL; Antoch G; Luedde T; Roderburg C; Loosen SH
J Clin Transl Res; 2023 Apr; 9(2):123-132. PubMed ID: 37179793
[TBL] [Abstract][Full Text] [Related]
2. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany.
Thoduka SG; Flegar L; Groeben C; Huber J; Eisenmenger N; Paulus T; Vogt K; Luster M; Abolmaali N
Curr Oncol; 2023 Dec; 30(12):10325-10335. PubMed ID: 38132386
[TBL] [Abstract][Full Text] [Related]
3. Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019.
Krieg S; Essing T; Krieg A; Roderburg C; Luedde T; Loosen SH
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565218
[TBL] [Abstract][Full Text] [Related]
4. Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.
Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K
J Gastroenterol Hepatol; 2022 Nov; 37(11):2173-2181. PubMed ID: 36031345
[TBL] [Abstract][Full Text] [Related]
5. Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.
Liu DM; Leung TW; Chow PK; Ng DC; Lee RC; Kim YH; Mao Y; Cheng YF; Teng GJ; Lau WY
Int J Surg; 2022 Jun; 102():106094. PubMed ID: 35662438
[TBL] [Abstract][Full Text] [Related]
6. Management of Liver Tumors during the COVID-19 Pandemic: The Added Value of Selective Internal Radiation Therapy (SIRT).
Bargellini I; Boni G; Traino AC; Bozzi E; Lorenzoni G; Bianchi F; Cervelli R; Depalo T; Crocetti L; Volterrani D; Cioni R
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640332
[TBL] [Abstract][Full Text] [Related]
7. Catheter-Directed Computed Tomography Hepatic Angiography for Yttrium-90 Selective Internal Radiotherapy of Hepatocellular Carcinoma Reduces Prophylactic Embolization of Extrahepatic Vessels.
Goh WXT; Leong S; Too CW; Cheng LT; Saffari SE; Lee RZ; Ng STS; Lo RHG; Tay KH; Chan SXJM; Gogna A; Irani FG; Venkatanarasimha N; Loke KSH; Chow PKH; Ng DCE; Urlings TAJ; Patel A; Damodharan K; Toh LHW; Tan BS
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):478-487. PubMed ID: 31705243
[TBL] [Abstract][Full Text] [Related]
8. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.
Mafeld S; Littler P; Hayhurst H; Manas D; Jackson R; Moir J; French J
J Gastrointest Cancer; 2020 Mar; 51(1):152-158. PubMed ID: 30911980
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
10. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS
Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
12. Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.
Oladeru OT; Miccio JA; Yang J; Xue Y; Ryu S; Stessin AM
J Gastrointest Oncol; 2016 Jun; 7(3):433-40. PubMed ID: 27284477
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy (SBRT) following Yttrium-90 (
Mee SF; Polan DF; Dewaraja YK; Cuneo KC; Gemmete JJ; Evans JR; Lawrence TS; Dow JS; Mikell JK
Phys Med Biol; 2023 Mar; 68(6):. PubMed ID: 36780696
[No Abstract] [Full Text] [Related]
14. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
15. [Selective internal radiotherapy (SIRT) of liver tumors].
Duan H; Hoffmann M
Radiologe; 2015 Jan; 55(1):48-52. PubMed ID: 25519898
[TBL] [Abstract][Full Text] [Related]
16. A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT).
Gosztonyi B; Pestalozzi B; Kenkel D; Engel-Bicik I; Kaufmann PA; Treyer V; Siebenhüner AR
J Gastrointest Oncol; 2022 Dec; 13(6):3240-3253. PubMed ID: 36636090
[TBL] [Abstract][Full Text] [Related]
17. Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.
Ricke J; Schinner R; Seidensticker M; Gasbarrini A; van Delden OM; Amthauer H; Peynircioglu B; Bargellini I; Iezzi R; De Toni EN; Malfertheiner P; Pech M; Sangro B
J Hepatol; 2021 Dec; 75(6):1387-1396. PubMed ID: 34454995
[TBL] [Abstract][Full Text] [Related]
18. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Ricke J; Klümpen HJ; Amthauer H; Bargellini I; Bartenstein P; de Toni EN; Gasbarrini A; Pech M; Peck-Radosavljevic M; Popovič P; Rosmorduc O; Schott E; Seidensticker M; Verslype C; Sangro B; Malfertheiner P
J Hepatol; 2019 Dec; 71(6):1164-1174. PubMed ID: 31421157
[TBL] [Abstract][Full Text] [Related]
19. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.
Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M
Ann Surg Oncol; 2017 Sep; 24(9):2465-2473. PubMed ID: 28653161
[TBL] [Abstract][Full Text] [Related]
20. Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.
Kolligs FT; Bilbao JI; Jakobs T; Iñarrairaegui M; Nagel JM; Rodriguez M; Haug A; D'Avola D; op den Winkel M; Martinez-Cuesta A; Trumm C; Benito A; Tatsch K; Zech CJ; Hoffmann RT; Sangro B
Liver Int; 2015 Jun; 35(6):1715-21. PubMed ID: 25443863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
